Scientific Publications & Presentations

Poster

One-dose carboplatin followed by vaccine-enhanced adoptive cell therapy (ECI®) improves outcomes compared to four-dose carboplatin in dogs with osteosarcoma

18th American Association for Cancer Research (AACR) Conference on The Science of Cancer Health Disparities | September 18–21, 2025

Jeffrey N Bryan, et al

Article

Autologous cancer cell vaccination, adoptive T-cell transfer, and interleukin-2 administration results in long-term survival for companion dogs with osteosarcoma

Journal of Veterinary Internal Medicine | July 10, 2020

Bryan K. Flesner, et al

Presentation

Cytokine Expression of Activated T cells in Dogs Undergoing Adoptive T cell Therapy for Osteosarcoma

2022 ACVIM Forum | June 24, 2022

Noe Reyes

This site may contain information on an investigational agent(s) or investigational uses of approved agent(s) that has not been reviewed or approved by the USDA or other regulatory authorities. ELIAS Animal Health does not endorse or recommend any unapproved use of its products. Please refer to product prescribing information, where available.

Make a Difference For Your Patients